{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:03:45Z","timestamp":1772262225729,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"am","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.bulcan.2023.12.010","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T08:46:50Z","timestamp":1710838010000},"page":"513-524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Orientation et prise en charge de la leuc\u00e9mie aigu\u00eb my\u00e9lo\u00efde n\u00e9onatale\u00a0: recommandations du comit\u00e9 leuc\u00e9mies de la SFCE"],"prefix":"10.1016","volume":"111","author":[{"given":"St\u00e9phane","family":"Ducassou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wadih","family":"Abou Chahla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Duployez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine","family":"Halfon-Domenech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beno\u00eet","family":"Brethon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyne","family":"Poir\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiphaine","family":"Adam de Beaumais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Lema\u00eetre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Sirvent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Petit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2023.12.010_bib0290","doi-asserted-by":"crossref","first-page":"101697","DOI":"10.1016\/j.canep.2020.101697","article-title":"Infant cancers in France: incidence and survival (2000\u20132014)","volume":"65","author":"Desandes","year":"2020","journal-title":"Cancer Epidemiol"},{"issue":"5","key":"10.1016\/j.bulcan.2023.12.010_bib0295","first-page":"762","article-title":"Biology and treatment of infant leukemias","volume":"9","author":"Pui","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.bulcan.2023.12.010_bib0300","series-title":"Leuc\u00e9mies aigu\u00ebs non lymphoblastiques n\u00e9onatales\/Exp\u00e9rience fran\u00e7aise de 1990\u00a0\u00e0 2010. Doctorat en M\u00e9decine","author":"Abou Chala","year":"2011"},{"issue":"3","key":"10.1016\/j.bulcan.2023.12.010_bib0305","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3346\/jkms.2001.16.3.366","article-title":"Congenital monoblastic leukemia with 9;11\u00a0translocation in monozygotic twins: a case report","volume":"16","author":"Park","year":"2001","journal-title":"J Korean Med Sci"},{"issue":"7","key":"10.1016\/j.bulcan.2023.12.010_bib0310","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1182\/blood-2002-12-3817","article-title":"Leukemia in twins: lessons in natural history","volume":"102","author":"Greaves","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bulcan.2023.12.010_bib0315","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/jnci\/88.1.24","article-title":"Parental alcohol consumption, cigarette smoking, and risk of infant leukemia: a Children's Cancer Group study","volume":"88","author":"Shu","year":"1996","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.bulcan.2023.12.010_bib0320","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1158\/1055-9965.EPI-04-0602","article-title":"Maternal diet and infant leukemia: the DNA topoisomerase II inhibitor hypothesis: a report from the children's oncology group","volume":"14","author":"Spector","year":"2005","journal-title":"Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol"},{"issue":"9","key":"10.1016\/j.bulcan.2023.12.010_bib0325","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1073\/pnas.97.9.4411","article-title":"Dietary flavonoids and the MLL gene: a pathway to infant leukemia?","volume":"97","author":"Ross","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.bulcan.2023.12.010_bib0330","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bulcan.2015.11.009","article-title":"Infant acute leukemia","volume":"103","author":"Brethon","year":"2016","journal-title":"Bull Cancer (Paris)"},{"issue":"3","key":"10.1016\/j.bulcan.2023.12.010_bib0335","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1046\/j.1365-2141.2002.03459.x","article-title":"Congenital leukaemia: the Dutch experience and review of the literature","volume":"117","author":"Bresters","year":"2002","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.bulcan.2023.12.010_bib0340","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00043426-200305000-00002","article-title":"Fetal and neonatal leukemia","volume":"25","author":"Isaacs","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"10.1016\/j.bulcan.2023.12.010_bib0345","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3109\/10428194.2014.938327","article-title":"Clinical and molecular epidemiology of neonatal leukemia in Brazil","volume":"56","author":"Moura","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1016\/j.bulcan.2023.12.010_bib0350","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1097\/HS9.0000000000000159","article-title":"Maintenance therapy with interleukin-2\u00a0for childhood AML: results of ELAM02\u00a0phase III randomized trial","volume":"2","author":"Petit","year":"2018","journal-title":"HemaSphere"},{"issue":"6","key":"10.1016\/j.bulcan.2023.12.010_bib0355","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.1097\/HS9.0000000000000316","article-title":"Is acute myeloblastic leukemia in children under 2\u00a0years of age a specific entity? A report from the FRENCH ELAM02\u00a0study group","volume":"3","author":"Blais","year":"2019","journal-title":"HemaSphere"},{"issue":"4","key":"10.1016\/j.bulcan.2023.12.010_bib0360","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/leu.2011.267","article-title":"Favorable outcome in infants with AML after intensive first- and second-line treatment: an AML-BFM study group report","volume":"26","author":"Creutzig","year":"2012","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.bulcan.2023.12.010_bib0365","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1182\/blood.V98.6.1714","article-title":"Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10\u00a0and 12\u00a0trials for acute myeloid leukemia","volume":"98","author":"Webb","year":"2001","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.bulcan.2023.12.010_bib0370","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1177\/0300060519872899","article-title":"Analysis of 59\u00a0cases of congenital leukemia reported between 2001\u00a0and 2016","volume":"47","author":"Zhang","year":"2019","journal-title":"J Int Med Res"},{"issue":"3","key":"10.1016\/j.bulcan.2023.12.010_bib0375","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1080\/10428194.2020.1845335","article-title":"Congenital acute myeloid leukemia: challenges and lessons. A 15-year experience from the UK","volume":"62","author":"Green","year":"2021","journal-title":"Leuk Lymphoma"},{"issue":"11S","key":"10.1016\/j.bulcan.2023.12.010_bib0380","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1016\/j.bulcan.2016.09.006","article-title":"How we harmonize HSCT clinical practices among the SFGM-TC centers","volume":"103","author":"Tipton","year":"2016","journal-title":"Bull Cancer (Paris)"},{"issue":"10","key":"10.1016\/j.bulcan.2023.12.010_bib0385","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood-2018-11-844688","article-title":"Juvenile myelomonocytic leukemia: who's the driver at the wheel?","volume":"133","author":"Niemeyer","year":"2019","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bulcan.2023.12.010_bib0390","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0146-0005(99)80036-6","article-title":"Congenital and neonatal leukemia","volume":"23","author":"Sande","year":"1999","journal-title":"Semin Perinatol"},{"issue":"2","key":"10.1016\/j.bulcan.2023.12.010_bib0395","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/bjh.15246","article-title":"Neonatal leukaemia","volume":"182","author":"Roberts","year":"2018","journal-title":"Br J Haematol"},{"issue":"2\u00a0Suppl","key":"10.1016\/j.bulcan.2023.12.010_bib0400","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.jaad.2005.04.038","article-title":"Congenital leukemia cutis with subsequent development of leukemia","volume":"54","author":"Zhang","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.bulcan.2023.12.010_bib0405","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.siny.2012.03.003","article-title":"Diagnosis and management of neonatal leukaemia","volume":"17","author":"van der\u00a0Linden","year":"2012","journal-title":"Semin Fetal Neonatal Med"},{"issue":"2","key":"10.1016\/j.bulcan.2023.12.010_bib0410","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/pbc.23053","article-title":"Siblings presenting with progressive congenital aleukemic leukemia cutis","volume":"57","author":"Agrawal","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"2\u00a0Pt2","key":"10.1016\/j.bulcan.2023.12.010_bib0415","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/01.AOG.0000232508.77614.6d","article-title":"Fetal leukemia with umbilical artery embolism and circulatory failure","volume":"109","author":"Shibasaki","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.bulcan.2023.12.010_bib0420","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000496097","article-title":"Morphological and immunophenotypic clues to the WHO categories of acute myeloid Leukaemia","volume":"141","author":"Bain","year":"2019","journal-title":"Acta Haematol"},{"issue":"3","key":"10.1016\/j.bulcan.2023.12.010_bib0425","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3324\/haematol.2021.279507","article-title":"Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML study group and EWOG-MDS","volume":"107","author":"Bertrums","year":"2022","journal-title":"Haematologica"},{"issue":"24","key":"10.1016\/j.bulcan.2023.12.010_bib0435","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1182\/blood-2013-07-515148","article-title":"GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia","volume":"122","author":"Roberts","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bulcan.2023.12.010_bib0440","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11899-016-0338-x","article-title":"Transient abnormal myelopoiesis and AML in Down syndrome: an update","volume":"11","author":"Bhatnagar","year":"2016","journal-title":"Curr Hematol Malig Rep"},{"issue":"12","key":"10.1016\/j.bulcan.2023.12.010_bib0445","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1038\/s41375-021-01414-y","article-title":"Clinical and biological aspects of myeloid leukemia in Down syndrome","volume":"35","author":"Boucher","year":"2021","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.bulcan.2023.12.010_bib0450","doi-asserted-by":"crossref","first-page":"e28188","DOI":"10.1002\/pbc.28188","article-title":"Clinical, cytogenetic, and molecular analyses of 17\u00a0neonates with transient abnormal myelopoiesis and nonconstitutional trisomy 21","volume":"67","author":"Yuzawa","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"15","key":"10.1016\/j.bulcan.2023.12.010_bib0455","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1182\/blood-2013-02-485524","article-title":"Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group","volume":"122","author":"Coenen","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bulcan.2023.12.010_bib0460","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12185-015-1759-3","article-title":"Somatic thrombopoietin (THPO) gene mutations in childhood myeloid leukemias","volume":"102","author":"Houwing","year":"2015","journal-title":"Int J Hematol"},{"issue":"16","key":"10.1016\/j.bulcan.2023.12.010_bib0465","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1182\/blood-2016-10-691428","article-title":"Mouse models of MLL leukemia: recapitulating the human disease","volume":"129","author":"Milne","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bulcan.2023.12.010_bib0470","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ng.3230","article-title":"The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias","volume":"47","author":"Andersson","year":"2015","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.bulcan.2023.12.010_bib0475","first-page":"2023","article-title":"Rapid intraclonal switch of lineage dominance in congenital leukaemia with a MLL gene rearrangement","volume":"9","author":"Ridge","year":"1995","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.bulcan.2023.12.010_bib0480","first-page":"162","article-title":"A lineage switch in acute monocytic leukemia. A case report","volume":"11","author":"Shimizu","year":"1989","journal-title":"Am J Pediatr Hematol Oncol"},{"issue":"7","key":"10.1016\/j.bulcan.2023.12.010_bib0485","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1080\/10428194.2018.1562185","article-title":"Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in KMT2A-rearranged acute lymphoblastic leukemia: a case report and review of the literature","volume":"60","author":"Fournier","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"10.1016\/j.bulcan.2023.12.010_bib0490","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2009-04-215152","article-title":"Novel prognostic subgroups in childhood 11q23\/MLL-rearranged acute myeloid leukemia: results of an international retrospective study","volume":"114","author":"Balgobind","year":"2009","journal-title":"Blood."},{"issue":"25","key":"10.1016\/j.bulcan.2023.12.010_bib0495","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1200\/JCO.19.00261","article-title":"Outcome of infants younger than 1\u00a0year with acute lymphoblastic leukemia treated with the interfant-06\u00a0protocol: results from an international phase III randomized study","volume":"37","author":"Pieters","year":"2019","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"5","key":"10.1016\/j.bulcan.2023.12.010_bib0500","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.molonc.2012.06.004","article-title":"Genetic and clinical characterization of 45\u00a0acute leukemia patients with MLL gene rearrangements from a single institution","volume":"6","author":"Cerveira","year":"2012","journal-title":"Mol Oncol"},{"issue":"2","key":"10.1016\/j.bulcan.2023.12.010_bib0505","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/leu.2017.213","article-title":"The MLL recombinome of acute leukemias in 2017","volume":"32","author":"Meyer","year":"2018","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.bulcan.2023.12.010_bib0510","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/leu.2015.177","article-title":"Multiplexed targeted sequencing of recurrent fusion genes in acute leukaemia","volume":"30","author":"Ruminy","year":"2016","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.bulcan.2023.12.010_bib0515","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.humpath.2008.02.018","article-title":"t(8;16)(p11;p13) predisposes to a transient but potentially recurring neonatal leukemia","volume":"39","author":"Wong","year":"2008","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.bulcan.2023.12.010_bib0520","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1097\/MPH.0000000000002119","article-title":"A case of congenital leukemia with MYB-GATA1\u00a0fusion gene in a female patient","volume":"44","author":"Ozono","year":"2022","journal-title":"J Pediatr Hematol Oncol"},{"issue":"12","key":"10.1016\/j.bulcan.2023.12.010_bib0525","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1182\/blood-2005-06-2448","article-title":"A prospective study of the natural history of transient leukemia (MPU) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481","volume":"107","author":"Massey","year":"2006","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.bulcan.2023.12.010_bib0530","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1182\/blood-2011-04-350017","article-title":"Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971","volume":"118","author":"Gamis","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bulcan.2023.12.010_bib0430","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/bjh.15390","article-title":"Guidelines for the investigation and management of transient leukaemia of Down syndrome","volume":"182","author":"Tunstall","year":"2018","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.bulcan.2023.12.010_bib0535","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/ng.2759","article-title":"The landscape of somatic mutations in Down syndrome-related myeloid disorders","volume":"45","author":"Yoshida","year":"2013","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.bulcan.2023.12.010_bib0540","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/iub.2197","article-title":"GATA1\u00a0and cooperating mutations in myeloid leukaemia of Down syndrome","volume":"72","author":"Garnett","year":"2020","journal-title":"IUBMB Life"},{"issue":"2","key":"10.1016\/j.bulcan.2023.12.010_bib0545","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ccell.2019.06.007","article-title":"Mechanisms of progression of myeloid preleukemia to transformed myeloid leukemia in children with Down syndrome","volume":"36","author":"Labuhn","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bulcan.2023.12.010_bib0550","unstructured":"Nos tout-petits [Internet]. Nos tout-petits. Disponible sur\u00a0: http:\/\/www.nostoutpetits.fr\/lassociation."},{"key":"10.1016\/j.bulcan.2023.12.010_bib0555","first-page":"60","volume":"1","year":"2015"},{"key":"10.1016\/j.bulcan.2023.12.010_bib0560","series-title":"Le soin est un humanisme","first-page":"49","author":"Fleury","year":"2019"},{"issue":"2","key":"10.1016\/j.bulcan.2023.12.010_bib0285","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/bjh.17746","article-title":"Updates on targeted therapies for acute myeloid leukaemia","volume":"196","author":"Kayser","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bulcan.2023.12.010_bib0565","series-title":"Corps \u00e0 corps. Souffrances du corps et travail psychique chez le b\u00e9b\u00e9, l\u2019enfant, l\u2019adolescent, la famille et les soignants","author":"Golse","year":"2014"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455124000456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455124000456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T05:54:42Z","timestamp":1715320482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455124000456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0007455124000456"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2023.12.010","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Orientation et prise en charge de la leuc\u00e9mie aigu\u00eb my\u00e9lo\u00efde n\u00e9onatale\u00a0: recommandations du comit\u00e9 leuc\u00e9mies de la SFCE","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2023.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}